Hairong Feng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Glioblastoma, the most common type of primary malignant brain tumor, is a devastating disease associated with a median survival of approximately 12 months. Here, we have tested E804, the commercially available indirubin derivatives, against U251 and U87 glioblastoma cells. Treatment with E804 significantly inhibits the growth of human glioblastoma cells(More)
  • 1